Relay Therapeutics (RLAY) EBIT Margin (QoQ) (2021 - 2026)

Relay Therapeutics (RLAY) EBIT Margin (QoQ) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Relay Therapeutics 3.43 Bn 3.43 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -175,352.00
Jun 30, 2025 -1.02 Mn
Mar 31, 2024 -922.05 Mn
Dec 31, 2023 921.99 Mn
Sep 30, 2023 8.88 Mn
Jun 30, 2023 -4.43 Mn
Mar 31, 2023 -1.60 Mn
Dec 31, 2022 -382,626.00
Sep 30, 2022 -365,052.00
Jun 30, 2022 -634,887.00
Mar 31, 2022 -302,512.00
Dec 31, 2021 -278,643.00
Sep 30, 2021 1.38 Mn
Jun 30, 2021 -1.85 Mn